Skip to main content
China Resources Pharmaceutical Group Limited logo

China Resources Pharmaceutical Group Limited — Investor Relations & Filings

Ticker · 3320 ISIN · HK0000311099 LEI · 3003004H1KDKMJ8JD874 HKEX Manufacturing
Open in API
Filings indexed 813 across all filing types
Latest filing 2023-09-27 Report Publication Anno…
Country HK Hong Kong
Listing HKEX 3320

About China Resources Pharmaceutical Group Limited

http://www.crpharm.com

China Resources Pharmaceutical Group Limited operates an integrated pharmaceutical value chain encompassing research and development, manufacturing, distribution, and retail of medicines and healthcare products. As an investment holding company, it manages a diverse portfolio focused primarily on the domestic market. Its manufacturing capabilities span multiple therapeutic areas, including chemical drugs, biological drugs, natural medicine, and traditional Chinese medicine. The group leverages its extensive distribution network and retail operations to ensure broad market coverage across China.

Recent filings

Filing Released Lang Actions
Letter to those shareholders who have elected to receive the printed form of corporate communications
Report Publication Announcement Classification · 95% confidence The document is a letter to shareholders enclosing the Interim Report 2023 of China Resources Pharmaceutical Group Limited. It includes an instruction slip for shareholders to elect or change their means of receiving future corporate communications, including printed or electronic forms. The document itself does not contain the interim report's financial data or analysis but serves as a cover letter and election form for receiving the report. The length is about 5259 characters, which is relatively short and mainly administrative. According to the 'Menu vs Meal' rule, this is an announcement or notification about the availability and delivery method of the interim report, not the report itself. Therefore, the appropriate classification is Report Publication Announcement (RPA).
2023-09-27 English
Interim Report 2023
Regulatory Filings
2023-09-27 English
CONTINUING CONNECTED TRANSACTIONS THE AMENDED BUSINESS TRAVEL SERVICES FRAMEWORK AGREEMENT 2023
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the Amended Business Travel Services Framework Agreement 2023 between the company and CR Digital, a connected person. It discusses the terms, annual caps, pricing policies, and compliance with the Listing Rules, specifically Chapter 14A concerning continuing connected transactions. The document is structured as a formal announcement to shareholders and the market about the amendment of a framework agreement and the related continuing connected transactions. It does not contain financial statements, audit opinions, or detailed financial results. It is not a report or presentation but an announcement of a corporate transaction and compliance with regulatory requirements. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2023-09-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 31 August 2023. It details movements in issued shares, share options, and other share capital related information for China Resources Pharmaceutical Group Limited. The document is a regulatory submission to the Hong Kong Exchanges and Clearing Limited, focusing on share capital movements and share options, not a financial report or earnings release. It is a regulatory filing related to share capital movements but does not announce a new share issue or capital change per se, nor is it a report publication announcement. Given the nature and format, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-09-04 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2023
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2023' and contains detailed unaudited condensed consolidated interim financial statements including profit or loss, comprehensive income, financial position, and notes. It references compliance with HKAS 34 'Interim financial reporting' and includes segment information and accounting policy changes. The document length is about 15,000 characters, indicating it is a full report rather than a brief announcement. The content and structure clearly identify it as an Interim / Quarterly Report containing substantive financial data and analysis for a period shorter than a full fiscal year (six months). Therefore, the appropriate classification is Interim / Quarterly Report (IR). H1 2023
2023-08-31 English
ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF KPC FOR THE SIX MONTHS ENDED 30 JUNE 2023
Regulatory Filings Classification · 95% confidence The document is an announcement of unaudited financial results for the six months ended 30 June 2023, explicitly referring to an interim report released by KPC Pharmaceuticals. It contains key financial data such as revenue, net profit, and assets, but it is relatively short (3854 characters) and primarily serves to inform about the release of the interim report rather than presenting a full comprehensive financial report itself. The text also advises shareholders to refer to the full interim report published on the Shanghai Stock Exchange website. This fits the pattern of a Regulatory Filing (RNS) as it is an announcement of financial results and reference to a report rather than the full interim report itself. Therefore, the appropriate classification is Regulatory Filings (RNS).
2023-08-30 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.